Radiotherapy enhancer brings back mass medicine

Radiotherapy is used in 60% of cancer cases, but it is prone to damaging nearby healthy cells and ineffective against cancer that has spread in metastasis. Nanobiotix has developed a nanomaterial product that enhances the x-ray exposure to tumour cells without increasing the dose inflicted on nearby healthy cells. They now show that the same product can be used to arm the immune system to attack cancer in metastasis as well.